Johnson & Johnson — Fact Sheet (July 2024)

3 slides from Johnson & Johnson's fact sheet, July 2024

Slide 1: Advancing the Future of Tuberculosis (TB) Treatment
Advancing the Future of Tuberculosis . (TB) Treatment: TB is one of the world’s deadliest infectious diseases, killing more people each year than malaria and HIV combined. The challenge is compounded by TB’s growing resistance to the most commonly used medicines. In fact, drug-resistant TB (DR-TB) i
Slide 2: TB discovery and development pipeline by stage
DISCOVERY STAGE EARLY STAGE LATE STAGE Discovery Pre-Clinical Phase I/IIa Phase IIb Phase III EU-PEARL UNITE4TB ERA4TB RESPIRI-NTM & RESPIRI-TB PAN-TB
Slide 3: Accelerating TB Innovation
Accelerating TB Innovation: Johnson & Johnson is committed to addressing the dual gap in innovation and health equity through the establishment of the J&J Centers for Global Health Discovery (Centers). This global network of research partnerships brings together our talent and expertise with that of